NCT07309770 2025-12-30Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard TherapiesFudan UniversityPhase 2 Recruiting90 enrolled
NCT00082706 2025-09-09Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantM.D. Anderson Cancer CenterPhase 2 Active not recruiting46 enrolled
NCT06683846 2025-08-24Ivonescimab in the Treatment of Multiple Advanced TumorsFudan UniversityPhase 2 Recruiting400 enrolled
NCT06638931 2025-05-28ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Active not recruiting28 enrolled